165 related articles for article (PubMed ID: 12434580)
1. Clinical safety and effectiveness of indorenate in essential hypertension.
Huape-Arreola S; Herrera-Abarca JE; Ruiz-Vega H; Hong E
Proc West Pharmacol Soc; 2002; 45():197-8. PubMed ID: 12434580
[No Abstract] [Full Text] [Related]
2. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
3. [Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs].
Lazebnik LB; Mikheeva OM; Drozdov VN; Petrakov AV; Sil'vestrova SIu
Eksp Klin Gastroenterol; 2008; (2):22-6. PubMed ID: 19148988
[No Abstract] [Full Text] [Related]
4. The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension.
Watanabe T; Arai Y; Mitsui Y; Kusaura T; Okawa W; Kajihara Y; Saito I
Clin Exp Hypertens; 2006 Jul; 28(5):439-49. PubMed ID: 16820341
[TBL] [Abstract][Full Text] [Related]
5. [Comparison between timolol maleate and alphamethyldopa in longterm treatment of essential hypertension (author's transl)].
G Ital Cardiol; 1981; 11(12):2110-6. PubMed ID: 7346307
[No Abstract] [Full Text] [Related]
6. Further evidence for a central antihypertensive effect of indorenate.
Hong E; Rion R; Aceves J; Benitez-King G; Anton-Tay F
Proc West Pharmacol Soc; 1987; 30():1-3. PubMed ID: 3476964
[No Abstract] [Full Text] [Related]
7. [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].
Grabner G; Michalek P; Pokorny D; Vormittag E
Arzneimittelforschung; 1966 Sep; 16(9):1174-9. PubMed ID: 6014738
[No Abstract] [Full Text] [Related]
8. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
9. Direct effects of new indorenate analogs on blood pressure of pithed rats.
Pérez-Alvarez V; Bobadilla RA; Hong E
Proc West Pharmacol Soc; 1998; 41():95-7. PubMed ID: 9836258
[No Abstract] [Full Text] [Related]
10. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
11. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
von Fallois J; Faülhaber HD
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials with CIBA 1507--Go, a new antihypertensive compound.
Misra RC; Gupta SK; Chuttani HK
J Assoc Physicians India; 1970 Dec; 18(12):979-82. PubMed ID: 5509035
[No Abstract] [Full Text] [Related]
13. [The exercise test with the bicycle ergometer: significance and limitations in the diagnostic and therapeutic evaluation of systemic arterial hypertension].
Bettinelli CA; Telò D; Cirelli S; Perini A; Savino S
Boll Soc Ital Cardiol; 1981; 26(10):1119-27. PubMed ID: 7349130
[No Abstract] [Full Text] [Related]
14. [Treatment of hypertension by labetalol (author's transl)].
Sternon J; Melot C; Contu E
Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
[No Abstract] [Full Text] [Related]
15. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
16. Effects of atenolol and losartan on baroreflex sensitivity and heart rate variability in uncomplicated essential hypertension.
Chern CM; Hsu HY; Hu HH; Chen YY; Hsu LC; Chao AC
J Cardiovasc Pharmacol; 2006 Feb; 47(2):169-74. PubMed ID: 16495752
[TBL] [Abstract][Full Text] [Related]
17. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
Weisser B; Vetter H; Mengden T
Dtsch Med Wochenschr; 2003 Mar; 128(11):541-4. PubMed ID: 12635025
[TBL] [Abstract][Full Text] [Related]
18. Current trends in the treatment of hypertension.
Wasir HS; Agarwal R
J Assoc Physicians India; 1993 Nov; 41(11):725-30. PubMed ID: 8005931
[No Abstract] [Full Text] [Related]
19. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
Basile J
J Clin Hypertens (Greenwich); 2002; 4(6):434-5. PubMed ID: 12461310
[No Abstract] [Full Text] [Related]
20. [Treatment of hypertension].
Kulke H
Fortschr Med; 1972 Dec; 90(35):1318-20. PubMed ID: 4633069
[No Abstract] [Full Text] [Related]
[Next] [New Search]
